Notizia - Recent Pharma, Healthcare and Biotech Happenings

MedTech News and Updates for Olympus, GE, Journey Biosciences, NeuroOne, Enovis

Olympus Launches New Gynecologic Power Morcellator; Journey Biosciences Launched NaviDKD; GE Board Approves Separation of GE HealthCare; FDA Approval to Enovis’s STAR Ankle; FDA Clearance to Deep Blue Medical’s T-Line Hernia Mesh; NeuroOne Completed Feasibility Study with its OneRF Ablation System

Olympus Launches New Gynecologic Power Morcellator for Its Contained Tissue Extraction System On November 30, 2022, Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, launched the moresolution™ Power Morcellator, manufactured by TROKAMED GmbH and available in the U.S. through a distribution agreement with Olympus America, Inc. The moresolution™ Morcellator is designed for advanced gynecologic procedures with large, calcified tissue specimens. The Olympus Contained Tissue Extraction System includes the PneumoLiner™, a first-of-its-kind containment device, and the mor...

Explore More...

Latest-pharma-happenings-for-hepion-nimbus-regeneron-bicycle-therapeutics

Hepion aces mid-stage study; Bicycle Therapeutics-Ionis collaboration; Nimbus raises $105M; Regeneron to support ISA Pharma

pharma-happenings-for-jnj-bayer-novo-prothena

Bayer’s CKD Drug; Enochian’s RNA Hijack for HBV; Novo Nordisk’s to get Prothena’s ATTR Amyloidosis Business; J&J’s COVID-19 Vaccine Struggle

Latest-pharma-happenings-for-rallybio-sanofi-eureka-lilly-unity-biotechnology

Unity’s advanced vascular eye disease trial; Rallybio raises $100 M; Sanofi bets over $1B for Eureka’s candidate; Lilly invests in MiNA;

pharma-happenings-for-arrowhead-sartorius-sirnaomics-agc-biologics

Arrowhead’s ARO-ENaC Clinical Trial; Sartorius Acquires Stake in CellGenix; AGC Biologics’s Cell & Gene Therapy; Sirnaomics Secures $105 Million

latest-medtech-updates-and-approval-of-devices

MedTech Market Industry: Approval of Devices, Therapy Address Market Needs | Clinical Outcomes Create New Value

Intellia’s Quest with CRISPR; Innovent, Synaffix ADC Tech Deal; Lilly’s Diabetes Blockbuster Tirzepatide; Polyphor’s Bleak Future

recent-pharma-happenings-for-insilico-sanofi-medtronic-blackstone-cellex

Insilico Medicine raises $255M; Sanofi & Translate Bio initiate trial; Medtronic gains expanded FDA approval; Blackstone, Cellex & Intellia form CAR-T startup

Horizon-Arrowhead-deal-Dr-Reddy-Lab-Drug-US-Launch-Targovax-ONCOS-102;-RedHill-Oral-Opaganib-COVID-19

Latest Medtech Commercial, Regulatory and Clinical Updates For – Abbott, BD, CooperVision, Procyrion, TricValve, and others

pharma-news-updates-for-amgen-verrica-nexturn-rosvivo-fennec

Amgen a leader in Undruggable Lung Cancer; Verrica’s Skin Disease Drug Delays; Fennec’s Faith in its Chemotherapy-Induced Hearing Loss Drug; Nexturn Bio’s Acquisition of RosVivo

Latest-pharma-biotech-news-updates-for-pieris-genentech-xilio-merck-bms-xencor

Pieris-Genentech deal; Xilio inks deal with Merck; BMS taps Xencor’s tech; GenSight’s gene therapy reports partial recovery

Another Failed NASH Drug; Takeda’s Dengue Shot; Innovent’s Cholangiocarcinoma Clinical Trial; TLX66 in AL Amyloidosis

Market & Competitive Assessment

Market Size & Forecast Assessment

Medical Devices

Market Research

Subscription

Competitive Intelligence

Business Consulting

Customized Solutions

Request for Proposal

Blog

Newsletter/Whitepaper

Infographics

Case Study

Events

Press Release

Analysis & Perspective

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Hepion aces mid-stage study; Bicycle Therapeutics-Ionis collaboration; Nimbus raises $105M; Regeneron to support ISA Pharma

Bayer’s CKD Drug; Enochian’s RNA Hijack for HBV; Novo Nordisk’s to get Prothena’s ATTR Amyloidosis Business; J&J’s COVID-19 Vaccine Struggle

Unity’s advanced vascular eye disease trial; Rallybio raises $100 M; Sanofi bets over $1B for Eureka’s candidate; Lilly invests in MiNA;

Arrowhead’s ARO-ENaC Clinical Trial; Sartorius Acquires Stake in CellGenix; AGC Biologics’s Cell & Gene Therapy; Sirnaomics Secures $105 Million

MedTech Market Industry: Approval of Devices, Therapy Address Market Needs | Clinical Outcomes Create New Value

Intellia’s Quest with CRISPR; Innovent, Synaffix ADC Tech Deal; Lilly’s Diabetes Blockbuster Tirzepatide; Polyphor’s Bleak Future

Insilico Medicine raises $255M; Sanofi & Translate Bio initiate trial; Medtronic gains expanded FDA approval; Blackstone, Cellex & Intellia form CAR-T startup

Horizon/ Arrowhead Deal; Dr Reddy’s Lab’s Drug US Launch; Targovax’s ONCOS-102; RedHill’s Oral Opaganib in COVID-19

More Views & Analysis

Age-related Hearing Loss Device Market Dynamics Expected to Step into Growth Quadrant

Eclipse, Medtronic, Aethlon, Cognoa, ObvioHealth, and others Continue to Veer MedTech Market Forward

Aelis Farma pockets $30M; Alcyone unveils $23M for AAV gene therapies; Progentec and GSK collaborate; Kozin bags $60M

Biogen’s Alzheimer’s Drug; FDA approval to Novo Nordisk’s Wegovy; Bluebird’s Gene Therapy

Latest Medtech Commercial, Regulatory and Clinical Updates For – Abbott, BD, CooperVision, Procyrion, TricValve, and others

Amgen a leader in Undruggable Lung Cancer; Verrica’s Skin Disease Drug Delays; Fennec’s Faith in its Chemotherapy-Induced Hearing Loss Drug; Nexturn Bio’s Acquisition of RosVivo

Pieris-Genentech deal; Xilio inks deal with Merck; BMS taps Xencor’s tech; GenSight’s gene therapy reports partial recovery

TLX66 in AL Amyloidosis; Takeda’s Dengue Shot; Innovent’s Cholangiocarcinoma Clinical Trial; Another Failed NASH Drug

Subscribe to our Updates

Daily

Weekly

Monthly